|
 Alzheimer's
 Merz - our research for your health. Therefore memantine has a low potential for day-day interactions in these multimorbid patients.
Alzheimer's: learn more about the different forms of diseases, current research, drugs, treatment, therapies and care. Alzheimer's is a topic that anyone of us should think about, because when growing old, everyone could be affected. Inform yourself about Alzheimer's now! The care for elderly people and their diseases are a topic for our society, whose importance grows each day. That's why we at Merz take Alzheimer's very serious, so that we can offer you the best drug for each treatment and therapy you need. Alzheimer's and Merz means research for your health. High-quality products and information about Alzheimer's can be found on our website. Visit us online and learn everything about Alzheimer's from one of Germany's leading health care companies. Our contribution to Alzheimer's: read here what we can do for you. Further links: Axura: Information for professionals.>>
Therefore memantine has a low potential for day-day interactions in these multimorbid patients.
Memantine , Alzheimer's Treatment . As memantine, in contrast to magnesium, blocks the NMDA receptor in the presence of sustained release of low glutamate concentrations, the influx of calcium is prevented (neuroprotection). Calcium enters into the cell, and through secondary processes, the signal is recognized. Such excitotoxicity ultimately leads to neuronal calcium overload and has been implicated in neurodegenerative disorders. Senile Dementia , Dementia Care . Memantine is well tolerated even in long-term therapy. Therefore memantine has a low potential for day-day interactions in these multimorbid patients. Merz is a leader in the field of Alzheimer research and developed the first drug for the treatment of moderate to severe Alzheimer s. A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. The starting point is the pathological release of glutamate, followed by elevated calcium concentrations. Alzheimer's Research , Alzheimer . At the same time, Memantine reduces caregiver time by more than 50 hours a month. A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. Demenzkranke , Verwirrtheit Gedächtnisstörungen Short Term Memory Loss Symptoms Of Alzheimer's Disease . Therefore memantine has a low potential for day-day interactions in these multimorbid patients. Alzheimer Erkrankung , Symptoms Of Alzheimer's Alzheimer's Disease Symptoms . However, due to the already elevated calcium concentration, the signal can no longer be detected (occurrence of dementia symptoms). Glutamatergic overstimulation results in neuronal damage, a phenomenon that has been termed excitotoxicity. The excitatory neurotransmitter glutamate plays an important part in the development of neurodegenerative diseases like dementia. Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Glutamate is the principal neurotransmitter in the brain. In studies of memantine, doctors assessed tolerability as good or very good in 93 percent of patients. Alzheimer's Drug Dementia Symptoms , Hirnleistungsstörungen . The excitatory effect of chronically released glutamate effects the degeneration of cortical and subcortical neurons, thus leading to the occurrence of dementia symptoms. Memantine is a NMDA receptor antagonist and protects the glutamatergic system from pathological activation. Clinically-relevant doses of memantine produce improvements in learning under conditions of tonic NMDA receptor activation in Alzheimer's disease. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. Demenz Krankheit Alzheimer Behandlung NMDA-Schutz Demenz Früherkennung , Mild Cognitive Impairment Altersdemenz . The safety of the combination therapy was investigated in a postmarketing surveillance study. During learning and memory processes (i e transient high glutamate release), memantine - the fast, voltage-dependent NMDA-receptor antagonist - leaves the NMDA receptor for a short time. A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. A significant improvement in cognitive performance is seen during treatment with the NMDA antagonist, especially when only small vessels are affected. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. The safety of the combination therapy was investigated in a postmarketing surveillance study. Alzheimer und Demenz , Glutamate Demenz Behandlung Demenz-Erkrankung . Recent results from a Phase III trial show that patients receiving a combination of memantine and donepezil performed significantly better than patients receiving donepezil and placebo. Due to its strong voltage-dependency, magnesium leaves the NMDA receptor. Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Alzheimer's Disease Alzheimer Therapie , Symptoms Of Dementia . The pathological, sustained release of low glutamate concentrations, from both neurones and surrounding glia cells, also displaces magnesium from the NMDA receptor channel. NMDA-Antagonist Forgetfulness , Glutamat Alzheimer Früherkennung . Memantine has been developed as a monotherapeutic. vaskuläre Demenz , Lewy Body Dementia Demenz Therapie Vascular Dementia . Gedächtnis , Demenz . Merz , Multi Infarct Dementia . Alzheimer's Dementia Axura , Vergesslichkeit Antidementiva Alzheimer's Caregiver . A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. Stages Of Alzheimer's Disease , Akatinol Alzheimer's Support Hirnleistungsstörung NMDA-Protection . Memantine produces symptomatic improvements in learning under conditions of tonic NMDA receptor activation in Alzheimer s disease. Due to its strong voltage-dependency, magnesium leaves the NMDA receptor. Alzheimer's , Demenzerkrankung Dementia . Calcium enters into the cell, and through secondary processes, the signal is recognized. Memory Loss Pseudodemenz Alzheimer's Care , Dementia Treatment . Memantine is the first representative of a new class of Alzheimer drugs, a moderate affinity NMDA-receptor antagonist. Dementia And Alzheimer's Alzheimer Krankheit , Demenzkrank . Alzheimer's Symptoms , Mental Confusion . Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Glutamate is the principal neurotransmitter in the brain. Dementia Medication Literatur , Erkennung Diagnose Studien . A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. Memantine is well tolerated even in long-term therapy. Memantine is well tolerated even in long-term therapy. Medikamentkombinationen , Demenz Medikament . Therapy , Help . Diagnosis , Information Literature . Studies , Combination . Treatment Alzheimer's Therapie Demenz Alzheimer Medikament , Medication Alzheimer's .
 Alzheimer's
|
